COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 1744: Articles 17431-17440  | Next

An Innovative antibody-based Plug-and-Play strategy for SARS-CoV-2
Tushir-Singh, J., Shivange, G. N., Gogoi, D.
10.1101/2021.03.11.434589 — Posted: 2021-03-12
Chimeric spike mRNA vaccines protect against sarbecovirus challenge in mice
Martinez, D. R., Schaefer, A., Leist, S. R., De la Cruz, G., West, A., Atochina-Vasserman, E. N., Parks, R., Barr, M., Li, D., Yount, B., Saunders, K. O., Weissman, D., Haynes, B., Montgomery, S. A., Baric, R. S.
10.1101/2021.03.11.434872 — Posted: 2021-03-12
I was facilitating everybody else's life. And mine had just ground to a halt: the COVID-19 pandemic and its impact on women in the UK
Herten-Crabb, A., Wenham, C.
10.1101/2021.03.12.21253136 — Posted: 2021-03-12
Exposure to SARS-CoV-2 within the household is associated with greater symptom severity and stronger antibody responses in a community-based sample of seropositive adults
Schrock, J. M., Ryan, D. T., Saber, R., Benbow, N., Vaught, L. A., Reiser, N., Velez, M. P., Hsieh, R., Newcomb, M. E., Demonbreun, A. R., Mustanski, B., McNally, E. M., D'Aquila, R., McDade, T. W.
10.1101/2021.03.11.21253421 — Posted: 2021-03-12
Impact of Vaccine Prioritization Strategies on Mitigating COVID-19: An Agent-Based Simulation Study using an Urban Region in the United States
Tatapudi, H. A., Das, R., Das, T. K.
10.1101/2021.03.12.21253447 — Posted: 2021-03-12
SARS-CoV-2 infection and risk of clinical sequelae during the post-acute phase: a retrospective cohort study
Daugherty, S. E., Guo, Y., Heath, K., Dasmarinas, M. C., Jubilo, K. G., Samranvedhya, J., Lipsitch, M., Cohen, K.
10.1101/2021.03.12.21253448 — Posted: 2021-03-12 Discussion: Onsite
Modelling, prediction and design of national COVID-19 lockdowns by stringency and duration
Mellone, A., Gong, Z., Scarciotti, G.
10.1101/2021.03.12.21253454 — Posted: 2021-03-12
COVID-19 vaccine hesitancy among undergraduate medical students: results from a nationwide survey in India
Jain, J., Saurabh, S., Goel, A. D., Gupta, M. K., Bhardwaj, P., Raghav, P. R.
10.1101/2021.03.12.21253444 — Posted: 2021-03-12
Sars-CoV-2 attack rate in reception and accommodation centres for asylum seekers: systematic review of outbreak media reports in Germany
Jahn, R., Hintermeier, M., Bozorgmehr, K.
10.1101/2021.03.12.21249641 — Posted: 2021-03-12
Prevalence of COVID-19 in Iran: Results of the first survey of the Iranian COVID-19 Serological Surveillance program
Khalagi, K., Gharibzadeh, S., Khalili, D., Mansournia, M. A., Mirab Samiee, S., Aghamohamadi, S., Mir-Mohammad-Ali Roodaki, M., Hashemi, S. M., Tayeri, K., Namdari Tabar, H., Azadmanesh, K., Tabrizi, J. S., Mohammad, K., Hajipour, F., Namaki, S., Raeisi, A., Ostovar, A.
10.1101/2021.03.12.21253442 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).